[EN] 4-SUBSTITUTED 1-ETHENYLSULFONYL-2-NITROBENZENE COMPOUNDS FOR TREATING SYNUCLEINOPATHIES<br/>[FR] COMPOSÉS DE 1-ÉTHÉNYLSULFONYL-2-NITROBENZÈNE À SUBSTITUTION EN POSITION 4 POUR LE TRAITEMENT DE SYNUCLÉINOPATHIES
申请人:UNIV BARCELONA AUTONOMA
公开号:WO2019161917A1
公开(公告)日:2019-08-29
The invention relates to compounds of formula I able to inhibit α- synuclein aggregation, their use in the treatment or prophylaxis of a synucleinopathy and to pharmaceutical compositions comprising said compounds of formula I : wherein R is selected from C1-C4-alkyl or cyclopropyl, wherein up to three hydrogen atoms of the C1-C4-alkyl or of the cyclopropyl are optionally substituted by radicals which are independently selected from F, CI, OH and NH2, provided there are no geminally bound OH groups if two or three OH groups are present.